Merit Medical Systems, Inc. (MMSI) CFO Sells $114,220.00 in Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) CFO Raul Jr. Parra sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $57.11, for a total value of $114,220.00. Following the completion of the transaction, the chief financial officer now owns 2,000 shares in the company, valued at $114,220. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Raul Jr. Parra also recently made the following trade(s):

  • On Thursday, March 14th, Raul Jr. Parra sold 5,000 shares of Merit Medical Systems stock. The shares were sold at an average price of $60.20, for a total value of $301,000.00.

Shares of NASDAQ MMSI opened at $56.75 on Friday. The company has a market capitalization of $3.16 billion, a price-to-earnings ratio of 33.58, a PEG ratio of 2.45 and a beta of 1.03. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.25 and a current ratio of 2.36. Merit Medical Systems, Inc. has a 52-week low of $47.30 and a 52-week high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Tuesday, April 23rd. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.01. The company had revenue of $238.35 million for the quarter, compared to analyst estimates of $236.53 million. Merit Medical Systems had a return on equity of 10.99% and a net margin of 4.68%. The firm’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.31 earnings per share. Analysts predict that Merit Medical Systems, Inc. will post 2.02 earnings per share for the current fiscal year.

A number of research firms recently commented on MMSI. ValuEngine cut Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Thursday, April 25th. Needham & Company LLC reiterated a “buy” rating on shares of Merit Medical Systems in a report on Thursday, April 25th. BidaskClub upgraded Merit Medical Systems from a “sell” rating to a “hold” rating in a report on Wednesday. Finally, Zacks Investment Research upgraded Merit Medical Systems from a “hold” rating to a “buy” rating and set a $62.00 price objective on the stock in a report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $67.80.

A number of hedge funds and other institutional investors have recently made changes to their positions in MMSI. Jennison Associates LLC increased its holdings in Merit Medical Systems by 29.3% in the first quarter. Jennison Associates LLC now owns 784,955 shares of the medical instruments supplier’s stock valued at $48,534,000 after buying an additional 177,811 shares during the last quarter. MML Investors Services LLC increased its holdings in Merit Medical Systems by 5.5% in the first quarter. MML Investors Services LLC now owns 9,533 shares of the medical instruments supplier’s stock valued at $589,000 after buying an additional 497 shares during the last quarter. Federated Investors Inc. PA increased its holdings in Merit Medical Systems by 178.1% in the first quarter. Federated Investors Inc. PA now owns 262,737 shares of the medical instruments supplier’s stock valued at $16,245,000 after buying an additional 168,276 shares during the last quarter. THB Asset Management purchased a new position in Merit Medical Systems in the first quarter valued at $474,000. Finally, Swiss National Bank increased its holdings in Merit Medical Systems by 3.2% in the first quarter. Swiss National Bank now owns 99,900 shares of the medical instruments supplier’s stock valued at $6,177,000 after buying an additional 3,100 shares during the last quarter. 96.58% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This story was first reported by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2019/05/12/merit-medical-systems-inc-mmsi-cfo-sells-114220-00-in-stock.html.

About Merit Medical Systems

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

See Also: Moving Average (MA)

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.